Table 4.
Serum hormone concentrations of non-pregnant dialysis patients and of subgroups according to menstrual cycle status and menopausal status
| Hormone | Serum concentration | |||||
|---|---|---|---|---|---|---|
| Non-pregnant | Menstrual cycle (n = 67)a | Menopause (n = 69) | ||||
| Regular | Irregular | Amenorrhea | No or functional | Pre- or true | ||
| (manufacturer and method) | (n = 69) | (n = 29) | (n = 13) | (n = 25) | (n = 46) | (n = 23) |
| hCG (Roche, ECLIA), mlU/ml | 1.0 (< 0.1–2.0) | 1.0 (0.1–1.0). | 0.1 (0.1–1.0) | 1.0 (0.5–6.0) | 0.1 (0.1–1.0) | 4.0 (1.5–7.45) |
| LH (Roche, ECLIA), mlU/ml | 9.45 (3.9–33.2) | 10.15 (3.98–27.6)b | 7.7 (4.2–11.6) | 10.4 (3.6–95.5) | 7.1 (3.6–15.7)b | 82.3 (4.4–120.8) |
| FSH (Roche, ECLIA), mlU/ml | 5.40 (3.90–22.7) | 5.0 (3.55–9.75)b | 4.4 (3.9–6.0) | 21.7 (4.2–80.0) | 4.6 (3.6–6.3)b | 58.3 (18.5–117) |
| AMH (Beckman-Coulter, ELISA; n = 33), ng/ml | 0.16 (< 0.08–3.2) | 0.66 (0.1–3.44) | 4.2 (0.86–6.3) | 0.08 (< 0.08–0.33) | 0.73 (0.31–5.46) | 0.08 (< 0.08- < 0.08) |
| n | 33 | 14 | 6 | 12 | 21 | 12 |
| AMH (Roche, ECLIA; n = 35), ng/ml | 0.19 (0.01–0.8)b | 0.36-(0.15–1.62)b | 0.37 (0.2–0.96) | 0.01 (0.01–0.04) | 0.38 (0.18–1.71)b | 0.01 (0.01–0.03) |
| n | 35b | 14b | 7 | 13 | 24b | 11 |
hCG human chorionic gonadotropin, LH luteinizing hormone, FSH follicle stimulating hormone, AMH anti-Müllerian hormone, ECLIA electrochemiluminescence immunoassay, ELISA enzyme linked immunosorbent assay
Data expressed as median (IQR); a unknown menstrual cycle status in two patients; b 1 missing